Filing Details
- Accession Number:
- 0001104659-19-065146
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-18 17:45:41
- Reporting Period:
- 2019-11-15
- Accepted Time:
- 2019-11-18 17:45:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1410939 | Iveric Bio Inc. | ISEE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1277478 | Glenn Sblendorio | C/O Iveric Bio, Inc. One Penn Plaza, 35Th Floor New York NY 10119 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-15 | 15,000 | $3.12 | 114,354 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- These shares were acquired in multiple transactions on November 15, 2019 at actual sales prices ranging from $3.12 to $3.131 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares acquired at each separate price.
- This total includes 6,249 shares acquired by the reporting person on September 15, 2019 under the issuer's 2016 Employee Stock Purchase Plan.